Skip to main content

Josep Castellví Vives

Institutions of which they are part

Translational Molecular Pathology
Vall Hebron Institut de Recerca

Josep Castellví Vives

Institutions of which they are part

Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Oncologia Translacional

IP: Jaume Reventós Puigjaner
Collaborators: Soledad Gallego Melcón, Manuel López Cano, José Placer Santos, Josep Sánchez de Toledo Codina, Joan Morote Robles, Ma Teresa Quiles Pérez, Maria Asuncion Perez Benavente, Eva Colas Ortega, Miguel Segura Ginard, Berta Diaz Feijoo, Manuel Armengol Carrasco, Josep Castellví Vives, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Marina Rigau Resina, Maria Antonia Arbos Via, Jacques Planas Morin, Josep Roma Castanyer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 57200
Reference: 2009 SGR 487
Duration: 01/01/2010 - 30/04/2014

Identificación de marcadores tumorales del adenocarcinoma endometrial a partir de un papel de 297 secuencias diferencialmente expresadas halladas por hibridación de Microarrays.

IP: Angel García Jiménez
Collaborators: Josep Castellví Vives, Antonio Gil Moreno
Funding agency: Instituto de Salud Carlos III
Funding: 65435
Reference: PI020733
Duration: 06/11/2002 - 30/06/2006

Investigación y desarrollo de productos y tecnologías de diagnóstico-pronóstico y aplicaciones terapéuticas en la enfermedad neoplásica.

IP: Jaume Reventós Puigjaner
Collaborators: Francina Munell Casadesus, Josep Castellví Vives, Antonio Gil Moreno
Funding agency: Oncnosis Pharma, AIE
Funding: 249550
Reference: CENIT/01/2006
Duration: 19/01/2006 - 31/12/2009

RTICC - Red Temática de Investigación cooperativa de cáncer

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Matilde Lleonart Pajarin, Cleofé Romagosa Pérez-Portabell, Teresa Moline Marimon, Carmela Iglesias i Felip, Josep Castellví Vives, Elena Antima Martinez Saez, Javier Hernandez Losa, Trond Aasen
Funding agency: Instituto de Salud Carlos III
Funding: 631500.61
Reference: RD06/0020/0104
Duration: 02/01/2007 - 31/12/2014

Related news

On World Cancer Research Day, we highlight the oncology research model of the Vall d'Hebron Campus that allows laboratory results to be transferred as quickly as possible to clinical practice.

Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.

The multidisciplinary paper on papillary thyroid cancer has been considered the best original article of 2021 in the journal Endocrinología, Diabetes y Nutrición

Related professionals

Teresa Vendrell Bayona

Teresa Vendrell Bayona

Genetics Medicine
Read more
Miquel Raspall Chaure

Miquel Raspall Chaure

Pediatric Neurology
Read more
Mireia Andres Villarreal

Mireia Andres Villarreal

Predoctoral researcher
Cardiovascular Diseases
Read more
Xavier Buxo Masip

Xavier Buxo Masip

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.